March 9 (Reuters) - Eli Lilly said on Monday a small number of basic Medicare drug plans may not follow the $50 per month cap ...
TIX100 is a specific, orally available TXNIP inhibitor originally developed for its beta-cell protective effects in diabetes. It has received FDA Investigational New Drug approval in diabetes and ...
By Dr. Liji Thomas, MD Stopping popular GLP-1 weight-loss drugs may reverse much of their benefit within a year, according to a large modeling analysis, raising questions about how long patients may ...
“The GLP-1 landscape is expected to broaden significantly,” said Dr. Christopher McGowan, a gastroenterologist who runs a weight loss clinic in Cary, North Carolina. “For the first time, medical ...
A new voluntary Medicare model starts in July, and it could save you $11,000 per year. But there are steps you need to take right now.
Obesity and type 2 diabetes are deeply interconnected. Yet, many diabetes prevention programs fail to adequately treat ...